: Inhibition of Abl kinases in the presence of docetaxel decreases cell proliferation and increases cell death in Kras G12D/+ ; p53 -/driven lung tumors. (D) Immunoblotting of lysates showed a decrease in Ki67 expression and increase in cleaved caspase 3 expression in mice given combination therapy compared to control mice and a corresponding decrease in phospho-ERK and cyclin D1, which are downstream targets of oncogenic Kras. Phospho-CrkL is a marker for Abl kinase activity while α-tubulin is a loading control. Figure 2D ) analysis showed no significant difference in total Yap1 protein expression in double treated mice compared to vehicle treated control mice. Phospho-CrkL (p-CrkL) expression is a marker of Abl kinase activity. (D) RT-qPCR analysis showed a decrease in mRNA transcript expression of the downstream Yap1 target, Birc5, which encodes the protein survivin, in mice treated with both GNF5 and docetaxel compared to vehicle control treated mice or mice treated with GNF5 or docetaxel alone (n= 3-4 mice per group, each RT-qPCR assay performed in triplicate). (E) Western blot analysis showed a decrease in protein expression of downstream transcriptional targets of Yap1, including survivin, c-Myc, S100A4, and cyclin D1. Graphs depict means and S.E.M.
